Clinical Trial Update: A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the long-term safety of ThermoProfen in knee osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• ThermoProfen

Snippet

Sponsor: ZARS Pharma Inc. | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED